GlassScriptPhysician profile
Scot A Murray
NPI 1659328102
$468.98
in general payments reported to CMS, 2019-2025
12 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.05 · 2020: $88.41 · 2021: $61.06 · 2022: $133 · 2023: $17.86 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $113.45 | 2025 | |
| Novo Nordisk INC | $75.00 | 2019-2022 | |
| Amgen INC. | $54.49 | 2021-2022 | |
| Madrigal Pharmaceuticals | $41.61 | 2025 | Rezdiffra |
| Biohaven Pharmaceutical Holding Company LTD. | $37.75 | 2022 | |
| Boston Scientific Corporation | $31.64 | 2020 | |
| Dexcom, INC. | $29.39 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.54 | 2022 | |
| Lilly USA, LLC | $17.86 | 2023 | Jardiance, Emgality |
| Janssen Pharmaceuticals, INC | $17.74 | 2021 | |
| Radius Health, INC. | $15.32 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scot Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.